These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. The use of physical and animal models to assess bioavailability. Barr WH Pharmacology; 1972; 8(1):55-101. PubMed ID: 4630161 [No Abstract] [Full Text] [Related]
49. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline. Van Aerde P; Moerman E; Van Severen R; Braeckman P Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890 [TBL] [Abstract][Full Text] [Related]
50. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
52. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin. Härtel G; Manninen V; Melin J; Apajalahti A Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756 [No Abstract] [Full Text] [Related]
53. Determination of ADME and bioavailability following intravenous, oral, and dermal routes of exposure. Saghir SA Curr Protoc Toxicol; 2009 Aug; Chapter 5():Unit 5.8. PubMed ID: 22714106 [TBL] [Abstract][Full Text] [Related]
54. [Studies on the absorption and activity onset of -mehyl-digoxin in patients with atrial fibrillation]. Limbourg P; Just H; Fiegel P; Michaelis J; Rosellen E Arzneimittelforschung; 1973 Jan; 23(1):60-3. PubMed ID: 4740697 [No Abstract] [Full Text] [Related]
55. [Biologic availability of drugs in humans and animals]. Wichliński L Pol Tyg Lek; 1975 Dec; 30(50):2111-2. PubMed ID: 1197106 [No Abstract] [Full Text] [Related]
56. Evidence for variable digoxin absorption as estimated by pharmacological response intensities. Schoenwald RD J Pharm Sci; 1974 Mar; 63(3):411-6. PubMed ID: 4820373 [No Abstract] [Full Text] [Related]
57. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination. Schumacher GE Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265 [No Abstract] [Full Text] [Related]
58. The absorption of digoxin tablets. Binnion PF Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):807-12. PubMed ID: 4426149 [No Abstract] [Full Text] [Related]
59. Paediatric oral biopharmaceutics: key considerations and current challenges. Batchelor HK; Fotaki N; Klein S Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013 [TBL] [Abstract][Full Text] [Related]
60. [Pharmacokinetic methods for the evaluation of intestinal absorption]. Kübler W Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]